The patients have suffered serious side effects due to injected insulin instead of semaglutide
It has been reported that several Austrians have been taken to the hospital after injecting fake Ozempic, as confirmed by health regulator.
Austria's Federal Office for Safety in Health Care (BASG) confirmed that the patients have suffered hypoglycaemia and seizures.
It is believed that the injections contained insulin instead of the weight loss drug, semaglutide.
The health regulator has urged doctors and patients to verify their medication stocks.
The surge in the sale of fake Ozempic has been flagged by the drug’s Danish manufacturer, Novo Nordisk.
They said: “We recognize the limitations of this exercise and are conducting physical investigations where warranted.”
Last week, the European Medicines Agency (EMA) and Medicines and Healthcare Products Regulatory Agency (MHRA) warned that fake Ozempic is in circulation throughout Europe and the UK.
The MHRA issued a statement: "All affected pens have been recalled and accounted for, and none of the pens have been supplied to UK patients."
